290 related articles for article (PubMed ID: 31665338)
21. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.
Lin C; Yang J; Fuller PJ; Jing H; Song Y; He W; Du Z; Luo T; Cheng Q; Yang S; Wang H; Li Q; Hu J;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):131-137. PubMed ID: 31774187
[TBL] [Abstract][Full Text] [Related]
22. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
[TBL] [Abstract][Full Text] [Related]
23. Sodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population.
Li Y; Liu Y; Li J; Wang X; Yu Y
J Clin Endocrinol Metab; 2016 Jan; 101(1):89-95. PubMed ID: 26565948
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism.
Nagano H; Kono T; Saiga A; Kubota Y; Fujimoto M; Felizola SJA; Ishiwata K; Tamura A; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Koide H; Takeshita N; Sakamoto S; Ban T; Yokote K; Nakamura Y; Ichikawa T; Uno T; Tanaka T
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31628466
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
26. Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done.
Tamura N; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Yonemoto T; Ogawa T; Kotani M; Usui T; Inoue T
Endocr J; 2020 Jul; 67(7):741-750. PubMed ID: 32249243
[TBL] [Abstract][Full Text] [Related]
27. Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.
Yuan Y; Li N; Liu Y; Wang M; Heizhati M; Zhu Q; Yao X; Luo Q
Endocrine; 2022 Mar; 75(3):889-898. PubMed ID: 34780033
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
29. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
Kobayashi H; Nakamura Y; Abe M; Tanabe A; Sone M; Katabami T; Kurihara I; Ichijo T; Tsuiki M; Izawa S; Wada N; Yoneda T; Takahashi K; Tamura K; Ogawa Y; Inagaki N; Yamamoto K; Rakugi H; Naruse M;
Endocr J; 2023 May; 70(5):489-500. PubMed ID: 36792218
[TBL] [Abstract][Full Text] [Related]
30. The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.
Kuo CC; Balakrishnan P; Hsein YC; Wu VC; Chueh SC; Chen YM; Wu KD; Wang MJ;
J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):587-98. PubMed ID: 25031295
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios.
Kim JH; Park KS; Hong AR; Shin CS; Kim SY; Kim SW
Endocrinol Metab (Seoul); 2016 Jun; 31(2):277-83. PubMed ID: 27184013
[TBL] [Abstract][Full Text] [Related]
32. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
33. High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
J Clin Hypertens (Greenwich); 2014 Jul; 16(7):488-96. PubMed ID: 24863855
[TBL] [Abstract][Full Text] [Related]
34. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.
Tanabe A; Naruse M; Takagi S; Tsuchiya K; Imaki T; Takano K
J Clin Endocrinol Metab; 2003 Jun; 88(6):2489-94. PubMed ID: 12788844
[TBL] [Abstract][Full Text] [Related]
35. A 120-Minute Saline Infusion Test for the Confirmation of Primary Aldosteronism: A Pilot Study.
Golani T; Bleier J; Kaplan A; Hod T; Sharabi Y; Leibowitz A; Grossman E; Shlomai G
Am J Hypertens; 2024 May; 37(6):415-420. PubMed ID: 38374690
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age.
Lee SH; Kim JW; Yoon HK; Koh JM; Shin CS; Kim SW; Kim JH
Endocrinol Metab (Seoul); 2021 Apr; 36(2):401-412. PubMed ID: 33789036
[TBL] [Abstract][Full Text] [Related]
37. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
38. Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.
Liu B; Hu J; Song Y; He W; Cheng Q; Wang Z; Feng Z; Du Z; Xu Z; Yang J; Li Q; Yang S;
Endocr Pract; 2021 Apr; 27(4):326-333. PubMed ID: 33779561
[TBL] [Abstract][Full Text] [Related]
39. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register.
Parra Ramírez P; Martín Rojas-Marcos P; Paja Fano M; González Boillos M; Peris BP; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; García Centeno R; Percovich JC; Rebollo Román Á; Gracia Gimeno P; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Furio Collao SA; Meneses D; Sampedro Nuñez MA; Escudero Quesada V; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Moya Mateo EM; Hanzu FA; Araujo-Castro M
Endocrine; 2024 May; 84(2):683-693. PubMed ID: 38008883
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L
Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
